Related Experiment Video

Updated: Jul 16, 2026

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection
06:56

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Published on: February 20, 2020

Pediatric acute otitis media: the case for delayed antibiotic treatment

Nicholas C Johnson1, Joel S Holger

  • 1Emergency Medicine Department, Regions Hospital, St. Paul, Minnesota 55101, USA.

The Journal of Emergency Medicine
|March 31, 2007
PubMed

Insights

Many children with acute otitis media (AOM) do not require antibiotics, as most cases resolve on their own. Evidence-based guidelines support a delayed antibiotic prescription approach for AOM, reducing antibiotic use and resistance.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Evidence-Based Medicine

Background:

  • Acute otitis media (AOM) is a common childhood illness frequently treated with antibiotics.
  • Recent research indicates that many AOM cases resolve spontaneously without complications.
  • Current antibiotic prescribing practices for AOM in children often exceed clinical necessity.

Purpose of the Study:

  • To review current guidelines for AOM treatment in children.
  • To evaluate the scientific evidence supporting various AOM treatment options.
  • To advocate for evidence-based guidelines incorporating a delayed antibiotic prescription strategy.

Main Methods:

  • Review of the American Academy of Pediatrics and American Academy of Family Physicians guideline for AOM.
  • Analysis of scientific literature on AOM treatment efficacy and outcomes.
  • Assessment of the impact of delayed antibiotic prescription on AOM resolution and antibiotic resistance.

Main Results:

  • A majority of childhood AOM infections are still treated with antibiotics, despite evidence of spontaneous resolution.
  • Delayed antibiotic prescription for selected children with AOM is supported by scientific evidence.
  • Implementation of these guidelines can reduce antibiotic prescribing and potentially lower antibiotic resistance rates.

Conclusions:

  • Evidence-based guidelines, including delayed antibiotic prescriptions, are recommended for managing AOM in children.
  • This approach can decrease antibiotic use, enhance parental satisfaction, and maintain AOM resolution rates.
  • Adoption of these cost-effective guidelines may mitigate the growing problem of antibiotic resistance.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...